PCSK9 Inhibitors and Neurocognitive Adverse Events: Exploring the FDA Directive and a Proposal for N-of-1 Trials
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PCSK9 Inhibitors and Neurocognitive Adverse Events: Exploring the FDA Directive and a Proposal for N-of-1 Trials
Authors
Keywords
-
Journal
DRUG SAFETY
Volume 38, Issue 6, Pages 519-526
Publisher
Springer Nature
Online
2015-05-19
DOI
10.1007/s40264-015-0296-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia
- (2015) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Statin Intolerance
- (2015) David H. Fitchett et al. CIRCULATION
- Do Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2015) Brian R. Ott et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuropsychiatric Adverse Events Associated with Statins: Epidemiology, Pathophysiology, Prevention and Management
- (2014) Marco Tuccori et al. CNS DRUGS
- Cognitive Effects of Statin Medications
- (2014) Brendan J. Kelley et al. CNS DRUGS
- PCSK9 and LDLR degradation
- (2014) Thomas A. Lagace CURRENT OPINION IN LIPIDOLOGY
- Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia
- (2014) Mehrul Hasnain et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
- (2014) Jennifer G. Robinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
- (2014) Erik Stroes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipid lowering with PCSK9 inhibitors
- (2014) Razvan T. Dadu et al. Nature Reviews Cardiology
- Plasma lipids and cerebral small vessel disease
- (2014) S. Schilling et al. NEUROLOGY
- Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
- (2014) Jens Niewoehner et al. NEURON
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
- (2014) Dirk J. Blom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-cardiovascular effects associated with statins
- (2014) C. S. Desai et al. BMJ-British Medical Journal
- Statins and Cognitive Function
- (2013) Karl Richardson et al. ANNALS OF INTERNAL MEDICINE
- Long-Term Effects of Secondary Prevention on Cognitive Function in Stroke Patients
- (2013) Abdel Douiri et al. CIRCULATION
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia
- (2013) Michael J. Koren et al. CIRCULATION
- Association of statin use with risk of dementia: A meta-analysis of prospective cohort studies
- (2013) Yu Song et al. Geriatrics & Gerontology International
- Statins and Cognition: A Systematic Review and Meta-analysis of Short- and Long-term Cognitive Effects
- (2013) Kristopher J. Swiger et al. MAYO CLINIC PROCEEDINGS
- Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia
- (2012) Frederick Raal et al. CIRCULATION
- Cochrane review on ‘Statins for the treatment of dementia’
- (2012) Bernadette McGuinness et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
- (2012) David Sullivan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population
- (2012) Iris Postmus et al. JOURNAL OF LIPID RESEARCH
- The Controversies of Statin Therapy
- (2012) J. Wouter Jukema et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
- (2012) Robert P Giugliano et al. LANCET
- LDL Cholesterol: The Lower the Better
- (2012) Seth S. Martin et al. MEDICAL CLINICS OF NORTH AMERICA
- Statins in the prevention of dementia and Alzheimer's disease: A meta-analysis of observational studies and an assessment of confounding
- (2012) William B. Wong et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Cognitive impairment and outcomes in older adult survivors of acute myocardial infarction: Findings from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status registry
- (2011) S. Michael Gharacholou et al. AMERICAN HEART JOURNAL
- PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke
- (2011) Estelle Rousselet et al. JOURNAL OF LIPID RESEARCH
- A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
- (2011) M. Sano et al. NEUROLOGY
- PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain
- (2010) Mali Liu et al. JOURNAL OF LIPID RESEARCH
- Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort
- (2010) D. Larry Sparks et al. Neurodegenerative Diseases
- Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
- (2010) H. H. Feldman et al. NEUROLOGY
- Trends in High Levels of Low-Density Lipoprotein Cholesterol in the United States, 1999-2006
- (2009) Elena V. Kuklina JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Statin-Associated Adverse Cognitive Effects: Survey Results from 171 Patients
- (2009) Marcella A Evans et al. PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More